Effect of less aggressive treatment on diabetic retinopathy severity scale scores: analyses of the RIDE and RISE open-label extension

OBJECTIVE: To evaluate factors associated with Diabetic Retinopathy Severity Scale (DRSS) changes with less frequent ranibizumab after induction therapy. METHODS AND ANALYSIS: Post hoc analyses of RIDE/RISE and their open-label extension (OLE). Analyses included patients with diabetic retinopathy (D...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberg, Roger A, Hill, Lauren, Davis, Tatiana, Stoilov, Ivaylo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341173/
https://www.ncbi.nlm.nih.gov/pubmed/36161830
http://dx.doi.org/10.1136/bmjophth-2022-001007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341173/
https://www.ncbi.nlm.nih.gov/pubmed/36161830
http://dx.doi.org/10.1136/bmjophth-2022-001007

Ejemplares similares